Industry Research Reports
Global Cyclic Peptide Service Market Research Report 2025
Industry: Service & Software
Published Date: 2025-03-11
Pages: 101 Pages
Report ld: 4634697
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Cyclic Peptide Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
North American market for Cyclic Peptide Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cyclic Peptide Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cyclic Peptide Service in Biopharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cyclic Peptide Service include GenScript Biotech, Eurogentec, LifeTein, Biopharma PEG Scientific, AnaSpec, Scitide, JPT, CD ComputaBio, Creative Peptides, Macrocyclos, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cyclic Peptide Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclic Peptide Service.
The Cyclic Peptide Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclic Peptide Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclic Peptide Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- GenScript Biotech
- Eurogentec
- LifeTein
- Biopharma PEG Scientific
- AnaSpec
- Scitide
- JPT
- CD ComputaBio
- Creative Peptides
- Macrocyclos
- Peptide Insitute
- Genepep
- Innovagen
- Bachem
- InnoPep
- Bio-Synthesis
- Biomatrik
- CPC Scientific
- Chinese Peptide
- Hangzhou All Peptide
- WuXi Discovery Services
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cyclic Peptide Custom Synthesis Service
- Cyclic Peptide Structure Analysis Services
- Cyclic Peptide Biological Activity Evaluation Services
- Others
Segment by Application
- Biopharmaceutical
- Scientific Research
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyclic Peptide Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclic Peptide Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cyclic Peptide Custom Synthesis Service
1.2.3 Cyclic Peptide Structure Analysis Services
1.2.4 Cyclic Peptide Biological Activity Evaluation Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cyclic Peptide Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cyclic Peptide Service Market Perspective (2020-2031)
2.2 Global Cyclic Peptide Service Growth Trends by Region
2.2.1 Global Cyclic Peptide Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cyclic Peptide Service Historic Market Size by Region (2020-2025)
2.2.3 Cyclic Peptide Service Forecasted Market Size by Region (2026-2031)
2.3 Cyclic Peptide Service Market Dynamics
2.3.1 Cyclic Peptide Service Industry Trends
2.3.2 Cyclic Peptide Service Market Drivers
2.3.3 Cyclic Peptide Service Market Challenges
2.3.4 Cyclic Peptide Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclic Peptide Service Players by Revenue
3.1.1 Global Top Cyclic Peptide Service Players by Revenue (2020-2025)
3.1.2 Global Cyclic Peptide Service Revenue Market Share by Players (2020-2025)
3.2 Global Cyclic Peptide Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cyclic Peptide Service Revenue
3.4 Global Cyclic Peptide Service Market Concentration Ratio
3.4.1 Global Cyclic Peptide Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclic Peptide Service Revenue in 2024
3.5 Global Key Players of Cyclic Peptide Service Head office and Area Served
3.6 Global Key Players of Cyclic Peptide Service, Product and Application
3.7 Global Key Players of Cyclic Peptide Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cyclic Peptide Service Breakdown Data by Type
4.1 Global Cyclic Peptide Service Historic Market Size by Type (2020-2025)
4.2 Global Cyclic Peptide Service Forecasted Market Size by Type (2026-2031)
5 Cyclic Peptide Service Breakdown Data by Application
5.1 Global Cyclic Peptide Service Historic Market Size by Application (2020-2025)
5.2 Global Cyclic Peptide Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cyclic Peptide Service Market Size (2020-2031)
6.2 North America Cyclic Peptide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cyclic Peptide Service Market Size by Country (2020-2025)
6.4 North America Cyclic Peptide Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cyclic Peptide Service Market Size (2020-2031)
7.2 Europe Cyclic Peptide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cyclic Peptide Service Market Size by Country (2020-2025)
7.4 Europe Cyclic Peptide Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cyclic Peptide Service Market Size (2020-2031)
8.2 Asia-Pacific Cyclic Peptide Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cyclic Peptide Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Cyclic Peptide Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cyclic Peptide Service Market Size (2020-2031)
9.2 Latin America Cyclic Peptide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cyclic Peptide Service Market Size by Country (2020-2025)
9.4 Latin America Cyclic Peptide Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclic Peptide Service Market Size (2020-2031)
10.2 Middle East & Africa Cyclic Peptide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cyclic Peptide Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Cyclic Peptide Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech
11.1.1 GenScript Biotech Company Details
11.1.2 GenScript Biotech Business Overview
11.1.3 GenScript Biotech Cyclic Peptide Service Introduction
11.1.4 GenScript Biotech Revenue in Cyclic Peptide Service Business (2020-2025)
11.1.5 GenScript Biotech Recent Development
11.2 Eurogentec
11.2.1 Eurogentec Company Details
11.2.2 Eurogentec Business Overview
11.2.3 Eurogentec Cyclic Peptide Service Introduction
11.2.4 Eurogentec Revenue in Cyclic Peptide Service Business (2020-2025)
11.2.5 Eurogentec Recent Development
11.3 LifeTein
11.3.1 LifeTein Company Details
11.3.2 LifeTein Business Overview
11.3.3 LifeTein Cyclic Peptide Service Introduction
11.3.4 LifeTein Revenue in Cyclic Peptide Service Business (2020-2025)
11.3.5 LifeTein Recent Development
11.4 Biopharma PEG Scientific
11.4.1 Biopharma PEG Scientific Company Details
11.4.2 Biopharma PEG Scientific Business Overview
11.4.3 Biopharma PEG Scientific Cyclic Peptide Service Introduction
11.4.4 Biopharma PEG Scientific Revenue in Cyclic Peptide Service Business (2020-2025)
11.4.5 Biopharma PEG Scientific Recent Development
11.5 AnaSpec
11.5.1 AnaSpec Company Details
11.5.2 AnaSpec Business Overview
11.5.3 AnaSpec Cyclic Peptide Service Introduction
11.5.4 AnaSpec Revenue in Cyclic Peptide Service Business (2020-2025)
11.5.5 AnaSpec Recent Development
11.6 Scitide
11.6.1 Scitide Company Details
11.6.2 Scitide Business Overview
11.6.3 Scitide Cyclic Peptide Service Introduction
11.6.4 Scitide Revenue in Cyclic Peptide Service Business (2020-2025)
11.6.5 Scitide Recent Development
11.7 JPT
11.7.1 JPT Company Details
11.7.2 JPT Business Overview
11.7.3 JPT Cyclic Peptide Service Introduction
11.7.4 JPT Revenue in Cyclic Peptide Service Business (2020-2025)
11.7.5 JPT Recent Development
11.8 CD ComputaBio
11.8.1 CD ComputaBio Company Details
11.8.2 CD ComputaBio Business Overview
11.8.3 CD ComputaBio Cyclic Peptide Service Introduction
11.8.4 CD ComputaBio Revenue in Cyclic Peptide Service Business (2020-2025)
11.8.5 CD ComputaBio Recent Development
11.9 Creative Peptides
11.9.1 Creative Peptides Company Details
11.9.2 Creative Peptides Business Overview
11.9.3 Creative Peptides Cyclic Peptide Service Introduction
11.9.4 Creative Peptides Revenue in Cyclic Peptide Service Business (2020-2025)
11.9.5 Creative Peptides Recent Development
11.10 Macrocyclos
11.10.1 Macrocyclos Company Details
11.10.2 Macrocyclos Business Overview
11.10.3 Macrocyclos Cyclic Peptide Service Introduction
11.10.4 Macrocyclos Revenue in Cyclic Peptide Service Business (2020-2025)
11.10.5 Macrocyclos Recent Development
11.11 Peptide Insitute
11.11.1 Peptide Insitute Company Details
11.11.2 Peptide Insitute Business Overview
11.11.3 Peptide Insitute Cyclic Peptide Service Introduction
11.11.4 Peptide Insitute Revenue in Cyclic Peptide Service Business (2020-2025)
11.11.5 Peptide Insitute Recent Development
11.12 Genepep
11.12.1 Genepep Company Details
11.12.2 Genepep Business Overview
11.12.3 Genepep Cyclic Peptide Service Introduction
11.12.4 Genepep Revenue in Cyclic Peptide Service Business (2020-2025)
11.12.5 Genepep Recent Development
11.13 Innovagen
11.13.1 Innovagen Company Details
11.13.2 Innovagen Business Overview
11.13.3 Innovagen Cyclic Peptide Service Introduction
11.13.4 Innovagen Revenue in Cyclic Peptide Service Business (2020-2025)
11.13.5 Innovagen Recent Development
11.14 Bachem
11.14.1 Bachem Company Details
11.14.2 Bachem Business Overview
11.14.3 Bachem Cyclic Peptide Service Introduction
11.14.4 Bachem Revenue in Cyclic Peptide Service Business (2020-2025)
11.14.5 Bachem Recent Development
11.15 InnoPep
11.15.1 InnoPep Company Details
11.15.2 InnoPep Business Overview
11.15.3 InnoPep Cyclic Peptide Service Introduction
11.15.4 InnoPep Revenue in Cyclic Peptide Service Business (2020-2025)
11.15.5 InnoPep Recent Development
11.16 Bio-Synthesis
11.16.1 Bio-Synthesis Company Details
11.16.2 Bio-Synthesis Business Overview
11.16.3 Bio-Synthesis Cyclic Peptide Service Introduction
11.16.4 Bio-Synthesis Revenue in Cyclic Peptide Service Business (2020-2025)
11.16.5 Bio-Synthesis Recent Development
11.17 Biomatrik
11.17.1 Biomatrik Company Details
11.17.2 Biomatrik Business Overview
11.17.3 Biomatrik Cyclic Peptide Service Introduction
11.17.4 Biomatrik Revenue in Cyclic Peptide Service Business (2020-2025)
11.17.5 Biomatrik Recent Development
11.18 CPC Scientific
11.18.1 CPC Scientific Company Details
11.18.2 CPC Scientific Business Overview
11.18.3 CPC Scientific Cyclic Peptide Service Introduction
11.18.4 CPC Scientific Revenue in Cyclic Peptide Service Business (2020-2025)
11.18.5 CPC Scientific Recent Development
11.19 Chinese Peptide
11.19.1 Chinese Peptide Company Details
11.19.2 Chinese Peptide Business Overview
11.19.3 Chinese Peptide Cyclic Peptide Service Introduction
11.19.4 Chinese Peptide Revenue in Cyclic Peptide Service Business (2020-2025)
11.19.5 Chinese Peptide Recent Development
11.20 Hangzhou All Peptide
11.20.1 Hangzhou All Peptide Company Details
11.20.2 Hangzhou All Peptide Business Overview
11.20.3 Hangzhou All Peptide Cyclic Peptide Service Introduction
11.20.4 Hangzhou All Peptide Revenue in Cyclic Peptide Service Business (2020-2025)
11.20.5 Hangzhou All Peptide Recent Development
11.21 WuXi Discovery Services
11.21.1 WuXi Discovery Services Company Details
11.21.2 WuXi Discovery Services Business Overview
11.21.3 WuXi Discovery Services Cyclic Peptide Service Introduction
11.21.4 WuXi Discovery Services Revenue in Cyclic Peptide Service Business (2020-2025)
11.21.5 WuXi Discovery Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Cyclic Peptide Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cyclic Peptide Custom Synthesis Service
Table 3. Key Players of Cyclic Peptide Structure Analysis Services
Table 4. Key Players of Cyclic Peptide Biological Activity Evaluation Services
Table 5. Key Players of Others
Table 6. Global Cyclic Peptide Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cyclic Peptide Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cyclic Peptide Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cyclic Peptide Service Market Share by Region (2020-2025)
Table 10. Global Cyclic Peptide Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cyclic Peptide Service Market Share by Region (2026-2031)
Table 12. Cyclic Peptide Service Market Trends
Table 13. Cyclic Peptide Service Market Drivers
Table 14. Cyclic Peptide Service Market Challenges
Table 15. Cyclic Peptide Service Market Restraints
Table 16. Global Cyclic Peptide Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cyclic Peptide Service Market Share by Players (2020-2025)
Table 18. Global Top Cyclic Peptide Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclic Peptide Service as of 2024)
Table 19. Ranking of Global Top Cyclic Peptide Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cyclic Peptide Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cyclic Peptide Service, Headquarters and Area Served
Table 22. Global Key Players of Cyclic Peptide Service, Product and Application
Table 23. Global Key Players of Cyclic Peptide Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cyclic Peptide Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cyclic Peptide Service Revenue Market Share by Type (2020-2025)
Table 27. Global Cyclic Peptide Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cyclic Peptide Service Revenue Market Share by Type (2026-2031)
Table 29. Global Cyclic Peptide Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cyclic Peptide Service Revenue Market Share by Application (2020-2025)
Table 31. Global Cyclic Peptide Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cyclic Peptide Service Revenue Market Share by Application (2026-2031)
Table 33. North America Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cyclic Peptide Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cyclic Peptide Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cyclic Peptide Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cyclic Peptide Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cyclic Peptide Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cyclic Peptide Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cyclic Peptide Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cyclic Peptide Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cyclic Peptide Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cyclic Peptide Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cyclic Peptide Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. GenScript Biotech Company Details
Table 49. GenScript Biotech Business Overview
Table 50. GenScript Biotech Cyclic Peptide Service Product
Table 51. GenScript Biotech Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 52. GenScript Biotech Recent Development
Table 53. Eurogentec Company Details
Table 54. Eurogentec Business Overview
Table 55. Eurogentec Cyclic Peptide Service Product
Table 56. Eurogentec Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 57. Eurogentec Recent Development
Table 58. LifeTein Company Details
Table 59. LifeTein Business Overview
Table 60. LifeTein Cyclic Peptide Service Product
Table 61. LifeTein Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 62. LifeTein Recent Development
Table 63. Biopharma PEG Scientific Company Details
Table 64. Biopharma PEG Scientific Business Overview
Table 65. Biopharma PEG Scientific Cyclic Peptide Service Product
Table 66. Biopharma PEG Scientific Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 67. Biopharma PEG Scientific Recent Development
Table 68. AnaSpec Company Details
Table 69. AnaSpec Business Overview
Table 70. AnaSpec Cyclic Peptide Service Product
Table 71. AnaSpec Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 72. AnaSpec Recent Development
Table 73. Scitide Company Details
Table 74. Scitide Business Overview
Table 75. Scitide Cyclic Peptide Service Product
Table 76. Scitide Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 77. Scitide Recent Development
Table 78. JPT Company Details
Table 79. JPT Business Overview
Table 80. JPT Cyclic Peptide Service Product
Table 81. JPT Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 82. JPT Recent Development
Table 83. CD ComputaBio Company Details
Table 84. CD ComputaBio Business Overview
Table 85. CD ComputaBio Cyclic Peptide Service Product
Table 86. CD ComputaBio Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 87. CD ComputaBio Recent Development
Table 88. Creative Peptides Company Details
Table 89. Creative Peptides Business Overview
Table 90. Creative Peptides Cyclic Peptide Service Product
Table 91. Creative Peptides Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 92. Creative Peptides Recent Development
Table 93. Macrocyclos Company Details
Table 94. Macrocyclos Business Overview
Table 95. Macrocyclos Cyclic Peptide Service Product
Table 96. Macrocyclos Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 97. Macrocyclos Recent Development
Table 98. Peptide Insitute Company Details
Table 99. Peptide Insitute Business Overview
Table 100. Peptide Insitute Cyclic Peptide Service Product
Table 101. Peptide Insitute Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 102. Peptide Insitute Recent Development
Table 103. Genepep Company Details
Table 104. Genepep Business Overview
Table 105. Genepep Cyclic Peptide Service Product
Table 106. Genepep Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 107. Genepep Recent Development
Table 108. Innovagen Company Details
Table 109. Innovagen Business Overview
Table 110. Innovagen Cyclic Peptide Service Product
Table 111. Innovagen Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 112. Innovagen Recent Development
Table 113. Bachem Company Details
Table 114. Bachem Business Overview
Table 115. Bachem Cyclic Peptide Service Product
Table 116. Bachem Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 117. Bachem Recent Development
Table 118. InnoPep Company Details
Table 119. InnoPep Business Overview
Table 120. InnoPep Cyclic Peptide Service Product
Table 121. InnoPep Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 122. InnoPep Recent Development
Table 123. Bio-Synthesis Company Details
Table 124. Bio-Synthesis Business Overview
Table 125. Bio-Synthesis Cyclic Peptide Service Product
Table 126. Bio-Synthesis Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 127. Bio-Synthesis Recent Development
Table 128. Biomatrik Company Details
Table 129. Biomatrik Business Overview
Table 130. Biomatrik Cyclic Peptide Service Product
Table 131. Biomatrik Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 132. Biomatrik Recent Development
Table 133. CPC Scientific Company Details
Table 134. CPC Scientific Business Overview
Table 135. CPC Scientific Cyclic Peptide Service Product
Table 136. CPC Scientific Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 137. CPC Scientific Recent Development
Table 138. Chinese Peptide Company Details
Table 139. Chinese Peptide Business Overview
Table 140. Chinese Peptide Cyclic Peptide Service Product
Table 141. Chinese Peptide Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 142. Chinese Peptide Recent Development
Table 143. Hangzhou All Peptide Company Details
Table 144. Hangzhou All Peptide Business Overview
Table 145. Hangzhou All Peptide Cyclic Peptide Service Product
Table 146. Hangzhou All Peptide Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 147. Hangzhou All Peptide Recent Development
Table 148. WuXi Discovery Services Company Details
Table 149. WuXi Discovery Services Business Overview
Table 150. WuXi Discovery Services Cyclic Peptide Service Product
Table 151. WuXi Discovery Services Revenue in Cyclic Peptide Service Business (2020-2025) & (US$ Million)
Table 152. WuXi Discovery Services Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Cyclic Peptide Service Picture
Figure 2. Global Cyclic Peptide Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cyclic Peptide Service Market Share by Type: 2024 VS 2031
Figure 4. Cyclic Peptide Custom Synthesis Service Features
Figure 5. Cyclic Peptide Structure Analysis Services Features
Figure 6. Cyclic Peptide Biological Activity Evaluation Services Features
Figure 7. Others Features
Figure 8. Global Cyclic Peptide Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cyclic Peptide Service Market Share by Application: 2024 VS 2031
Figure 10. Biopharmaceutical Case Studies
Figure 11. Scientific Research Case Studies
Figure 12. Others Case Studies
Figure 13. Cyclic Peptide Service Report Years Considered
Figure 14. Global Cyclic Peptide Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cyclic Peptide Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cyclic Peptide Service Market Share by Region: 2024 VS 2031
Figure 17. Global Cyclic Peptide Service Market Share by Players in 2024
Figure 18. Global Top Cyclic Peptide Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclic Peptide Service as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cyclic Peptide Service Revenue in 2024
Figure 20. North America Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cyclic Peptide Service Market Share by Country (2020-2031)
Figure 22. United States Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cyclic Peptide Service Market Share by Country (2020-2031)
Figure 26. Germany Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cyclic Peptide Service Market Share by Region (2020-2031)
Figure 34. China Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cyclic Peptide Service Market Share by Country (2020-2031)
Figure 42. Mexico Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cyclic Peptide Service Market Share by Country (2020-2031)
Figure 46. Turkey Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cyclic Peptide Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. GenScript Biotech Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 50. Eurogentec Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 51. LifeTein Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 52. Biopharma PEG Scientific Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 53. AnaSpec Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 54. Scitide Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 55. JPT Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 56. CD ComputaBio Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 57. Creative Peptides Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 58. Macrocyclos Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 59. Peptide Insitute Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 60. Genepep Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 61. Innovagen Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 62. Bachem Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 63. InnoPep Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 64. Bio-Synthesis Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 65. Biomatrik Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 66. CPC Scientific Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 67. Chinese Peptide Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 68. Hangzhou All Peptide Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 69. WuXi Discovery Services Revenue Growth Rate in Cyclic Peptide Service Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cyclic Peptide Service market?
The top companies in the global Cyclic Peptide Service market are GenScript Biotech、Eurogentec、LifeTein.
Related Reports
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cyclic Peptide Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 172
USD 4900.00
(Single User License)
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cyclic Peptide Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 117
USD 4250.00
(Single User License)
Cyclic Peptide Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 144
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2026
The global Cyclic Peptide Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 147
USD 2900.00
(Single User License)
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cyclic Peptide Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cyclic Peptide Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 165
USD 4900.00
(Single User License)
Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 148
USD 3950.00
(Single User License)
Global and United States Cyclic Peptide Service Market Report & Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 139
USD 4350.00
(Single User License)
Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 150
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2024
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 102
USD 2900.00
(Single User License)
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cyclic Peptide Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 172
USD 4900.00 (Single User License)Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cyclic Peptide Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 117
USD 4250.00 (Single User License)Cyclic Peptide Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 144
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2026
The global Cyclic Peptide Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 147
USD 2900.00 (Single User License)Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cyclic Peptide Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cyclic Peptide Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 165
USD 4900.00 (Single User License)Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 148
USD 3950.00 (Single User License)Global and United States Cyclic Peptide Service Market Report & Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 139
USD 4350.00 (Single User License)Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 150
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2024
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 102
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now